Clinical Trial Update: Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects [Phase 1]

View source ↗

Summary

Phase 1 three-part study (single-ascending-dose, multiple-ascending-dose, and cross-over) of ZP-059 in healthy and asthmatic subjects; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• ZP-059

Snippet

Sponsor: Zambon SpA | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 1 | Status: COMPLETED | Results posted: 2021-11-15